Atlas Trials

Adult Acute Myeloid Leukemia With Minimal Differentiation

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Adult Acute Myeloid Leukemia With Minimal Differentiation

RecordFirmDate
Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia (NCT01870596)National Cancer Institute (NCI)2013-05-01
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia (NCT01361464)National Cancer Institute (NCI)2011-05-01
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia (NCT01260714)National Cancer Institute (NCI)2010-12-01
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia (NCT01168219)National Cancer Institute (NCI)2010-07-15
Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders (NCT00588991)National Cancer Institute (NCI)2008-02-04
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase (NCT00383474)National Cancer Institute (NCI)2006-08-01
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission (NCT00093470)National Cancer Institute (NCI)2004-08-18

Track Adult Acute Myeloid Leukemia With Minimal Differentiation automatically

Every clearance here is in the API, with alerts when new ones post.